Drug Coding

The following sections will assist healthcare professionals and payers by providing appropriate coding and billing information associated with the treatment of melanoma. Although new claims cannot be submitted with ICD-9-CM codes as of 10/1/15, these may still be needed for submitting old claims that occurred before 10/1/15. We will, therefore, continue to provide the 2 sets of codes through the end of 2015. Read More ›

The following sections will assist healthcare professionals and payers by providing appropriate coding and billing information associated with the treatment of patients with prostate cancer. Although new claims cannot be submitted with ICD-9-CM codes as of 10/1/15, these may still be needed for submitting old claims that occurred before 10/1/15. We will, therefore, continue to provide the 2 sets of codes through the end of the year. Read More ›

The following sections will assist healthcare professionals and payers by providing appropriate coding and billing information associated with the treatment of breast cancer. Although new claims cannot be submitted with ICD-9-CM codes as of 10/1/15, these may still be needed for submitting old claims that occurred before 10/1/15. We will, therefore, continue to provide the 2 sets of codes through the end of the year. Read More ›

The following sections will assist healthcare professionals and payers by providing appropriate coding and billing information associated with the treatment of lung cancer. Read More ›

The following sections will assist healthcare professionals and payers by providing appropriate coding and billing information associated with the treatment of prostate cancer. Read More ›

This article assists healthcare professionals and payers by providing appropriate coding and billing information associated with the treatment of leukemia. Read More ›

The following sections will assist healthcare professionals and payers by providing appropriate coding and billing information associated with the treatment of colorectal cancer. Read More ›

The following sections will assist healthcare professionals and payers by providing appropriate coding and billing information associated with the treatment of multiple myeloma. Read More ›

FDA-Approved Medications Used for the Treatment of Renal Cell Carcinoma Read More ›

The following sections will assist healthcare professionals and payers by providing appropriate coding and billing information associated with the treatment of melanoma. The following sections include:
  • Associated ICD-9-CM codes used for the classification of melanoma
  • Drugs that have been FDA approved in the treatment of melanoma
  • Drugs that are Compendia-listed for off-label use for melanoma based on clinical studies that suggest beneficial use in some cases. Please note: If a check mark appears in the FDA column, it will NOT appear in the Compendia off-label use column
  • Corresponding HCPCS/CPT® codes and code descriptions
  • Drugs listed in the Compendia section have no FDA-approved uses for melanoma. However, drugs in the FDA-approved section are FDA approved for at least 1 of the melanoma ICD-9-CM codes but may also have Compendia-listed uses as well.
Read More ›

Page 1 of 4

Subscribe to
Urology Practice Management

Stay up to date with urology news & updates by subscribing to recieve the free UPM print publications or weekly e‑Newsletter.

I'd like to recieve: